A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.
about
A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumorsPhase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumorsHigh-dose chemotherapy combined with autologous peripheral blood stem cell transplantation in children with advanced malignant solid tumors: A retrospective analysis of 38 cases
P2860
A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A multi-center phase Ib study ...... ts with advanced solid tumors.
@ast
A multi-center phase Ib study ...... ts with advanced solid tumors.
@en
type
label
A multi-center phase Ib study ...... ts with advanced solid tumors.
@ast
A multi-center phase Ib study ...... ts with advanced solid tumors.
@en
prefLabel
A multi-center phase Ib study ...... ts with advanced solid tumors.
@ast
A multi-center phase Ib study ...... ts with advanced solid tumors.
@en
P2093
P2860
P356
P1476
A multi-center phase Ib study ...... ts with advanced solid tumors.
@en
P2093
Aru Narendren
Cynthia Herzog
James Whitlock
Jessica Boklan
Katherine Rolla
Margaret E Macy
Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC)
Robert J Arceci
Rochelle Bagatell
P2860
P304
P356
10.1002/PBC.24278
P577
2012-09-28T00:00:00Z